VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q58227556 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000205.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q58227556‏
024 ‎‡a 0000-0002-9116-948X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q58227556‏
100 0 ‎‡a John Scott‏ ‎‡9 nl‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a জন স্কট‏ ‎‡9 bn‏
400 0 ‎‡a John Scott‏ ‎‡c American statistician‏ ‎‡9 en‏
670 ‎‡a Author's A chart review of cyproheptadine for stimulant-induced weight loss‏
670 ‎‡a Author's A classification of contour deformities after bariatric weight loss: the Pittsburgh Rating Scale‏
670 ‎‡a Author's A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reports‏
670 ‎‡a Author's A pilot study of brief interpersonal psychotherapy for depression among women‏
670 ‎‡a Author's Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy‏
670 ‎‡a Author's Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information‏
670 ‎‡a Author's An open-label trial of enhanced brief interpersonal psychotherapy in depressed mothers whose children are receiving psychiatric treatment‏
670 ‎‡a Author's Application of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice‏
670 ‎‡a Author's Assessment of TRAM aesthetics: the importance of subunit integration‏
670 ‎‡a Author's Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).‏
670 ‎‡a Author's Bayesian methods for design and analysis of safety trials‏
670 ‎‡a Author's BayesWeb: a user-friendly platform for exploratory Bayesian analysis of safety signals from small clinical trials‏
670 ‎‡a Author's Can Natural Language Processing Improve the Efficiency of Vaccine Adverse Event Report Review?‏
670 ‎‡a Author's CBER’s Experience With Adaptive Design Clinical Trials‏
670 ‎‡a Author's Comment‏
670 ‎‡a Author's Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women".‏
670 ‎‡a Author's Comment: Statisticians Staying Involved in Benefit-Risk Assessment‏
670 ‎‡a Author's Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product‏
670 ‎‡a Author's Daytime symptoms in primary insomnia: a prospective analysis using ecological momentary assessment‏
670 ‎‡a Author's Decision support environment for medical product safety surveillance‏
670 ‎‡a Author's Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells‏
670 ‎‡a Author's Functional impairment in the remission phase of bipolar disorder‏
670 ‎‡a Author's Hypothyroidism in patients with bipolar I disorder treated primarily with lithium.‏
670 ‎‡a Author's Identifying Similar Cases in Document Networks Using Cross-Reference Structures‏
670 ‎‡a Author's Initial nicotine sensitivity in humans as a function of impulsivity‏
670 ‎‡a Author's Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study‏
670 ‎‡a Author's Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians‏
670 ‎‡a Author's Missing data issues at the FDA Center for Biologics Evaluation and Research‏
670 ‎‡a Author's Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer‏
670 ‎‡a Author's Pain predicts longer time to remission during treatment of recurrent depression.‏
670 ‎‡a Author's Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs‏
670 ‎‡a Author's Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches‏
670 ‎‡a Author's Severity of tobacco abstinence symptoms varies by time of day‏
670 ‎‡a Author's Sex differences in long-term smoking cessation rates due to nicotine patch‏
670 ‎‡a Author's Simulating adverse event spontaneous reporting systems as preferential attachment networks: application to the Vaccine Adverse Event Reporting System‏
670 ‎‡a Author's Statistical analysis of longitudinal psychiatric data with dropouts‏
670 ‎‡a Author's Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder‏
670 ‎‡a Author's Use of OSWALD for analyzing longitudinal data with informative dropout‏
670 ‎‡a Author's Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking‏
909 ‎‡a (orcid) 000000029116948x‏ ‎‡9 1‏
912 ‎‡a comment‏ ‎‡A Comment‏ ‎‡9 1‏
919 ‎‡a bayesianmethodsfordesignandanalysisofsafetytrials‏ ‎‡A Bayesian methods for design and analysis of safety trials‏ ‎‡9 1‏
919 ‎‡a assessmentoftramaestheticstheimportanceofsubunitintegration‏ ‎‡A Assessment of TRAM aesthetics: the importance of subunit integration‏ ‎‡9 1‏
919 ‎‡a applicationofbioluminescenceimagingtothepredictionoflethalityinvacciniavirusinfectedmice‏ ‎‡A Application of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice‏ ‎‡9 1‏
919 ‎‡a openlabeltrialofenhancedbriefinterpersonalpsychotherapyindepressedmotherswhosechildrenarereceivingpsychiatrictreatment‏ ‎‡A An open-label trial of enhanced brief interpersonal psychotherapy in depressed mothers whose children are receiving psychiatric treatment‏ ‎‡9 1‏
919 ‎‡a addressingpriordataconflictwithempiricalmetaanalyticpredictivepriorsinclinicalstudieswithhistoricalinformation‏ ‎‡A Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information‏ ‎‡9 1‏
919 ‎‡a acutetreatmentoutcomesinpatientswithbipolar1disorderandcomorbidborderlinepersonalitydisorderreceivingmedicationandpsychotherapy‏ ‎‡A Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy‏ ‎‡9 1‏
919 ‎‡a pilotstudyofbriefinterpersonalpsychotherapyfordepressionamongwomen‏ ‎‡A A pilot study of brief interpersonal psychotherapy for depression among women‏ ‎‡9 1‏
919 ‎‡a newalgorithmicapproachfortheextractionoftemporalassociationsfromclinicalnarrativeswithanapplicationtomedicalproductsafetysurveillancereports‏ ‎‡A A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reports‏ ‎‡9 1‏
919 ‎‡a classificationofcontourdeformitiesafterbariatricweightlossthepittsburghratingscale‏ ‎‡A A classification of contour deformities after bariatric weight loss: the Pittsburgh Rating Scale‏ ‎‡9 1‏
919 ‎‡a chartreviewofcyproheptadineforstimulantinducedweightloss‏ ‎‡A A chart review of cyproheptadine for stimulant-induced weight loss‏ ‎‡9 1‏
919 ‎‡a associationruleminingintheusvaccineadverseeventreportingsystemvaers‏ ‎‡A Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).‏ ‎‡9 1‏
919 ‎‡a variabilityininitialnicotinesensitivityduetosexhistoryofotherdruguseandparentalsmoking‏ ‎‡A Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking‏ ‎‡9 1‏
919 ‎‡a useofoswaldforanalyzinglongitudinaldatawithinformativedropout‏ ‎‡A Use of OSWALD for analyzing longitudinal data with informative dropout‏ ‎‡9 1‏
919 ‎‡a 2yearoutcomesforinterpersonalandsocialrhythmtherapyinindividualswithbipolar1disorder‏ ‎‡A Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder‏ ‎‡9 1‏
919 ‎‡a statisticalanalysisoflongitudinalpsychiatricdatawithdropouts‏ ‎‡A Statistical analysis of longitudinal psychiatric data with dropouts‏ ‎‡9 1‏
919 ‎‡a simulatingadverseeventspontaneousreportingsystemsaspreferentialattachmentnetworksapplicationtothevaccineadverseeventreportingsystem‏ ‎‡A Simulating adverse event spontaneous reporting systems as preferential attachment networks: application to the Vaccine Adverse Event Reporting System‏ ‎‡9 1‏
919 ‎‡a sexdifferencesinlongtermsmokingcessationratesduetonicotinepatch‏ ‎‡A Sex differences in long-term smoking cessation rates due to nicotine patch‏ ‎‡9 1‏
919 ‎‡a severityoftobaccoabstinencesymptomsvariesbytimeofday‏ ‎‡A Severity of tobacco abstinence symptoms varies by time of day‏ ‎‡9 1‏
919 ‎‡a samplesizeestimationinsinglearmclinicaltrialswithmultipletestingunderfrequentistandbayesianapproaches‏ ‎‡A Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches‏ ‎‡9 1‏
919 ‎‡a passiveimmunotherapiesprotectwrvfireandihdjlucvacciniavirusinfectedmicefromlethalitybyreducingviralloadsintheupperrespiratorytractandinternalorgans‏ ‎‡A Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs‏ ‎‡9 1‏
919 ‎‡a painpredictslongertimetoremissionduringtreatmentofrecurrentdepression‏ ‎‡A Pain predicts longer time to remission during treatment of recurrent depression.‏ ‎‡9 1‏
919 ‎‡a novelalgorithmsforimprovedpatternrecognitionusingtheusfdaadverseeventnetworkanalyzer‏ ‎‡A Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer‏ ‎‡9 1‏
919 ‎‡a missingdataissuesatthefdacenterforbiologicsevaluationandresearch‏ ‎‡A Missing data issues at the FDA Center for Biologics Evaluation and Research‏ ‎‡9 1‏
919 ‎‡a metabolicsyndromeinbipolardisorderfindingsfromthebipolardisordercenterforpennsylvanians‏ ‎‡A Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians‏ ‎‡9 1‏
919 ‎‡a interpersonalpsychotherapyfordepressionwithpanicspectrumsymptomsapilotstudy‏ ‎‡A Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study‏ ‎‡9 1‏
919 ‎‡a initialnicotinesensitivityinhumansasafunctionofimpulsivity‏ ‎‡A Initial nicotine sensitivity in humans as a function of impulsivity‏ ‎‡9 1‏
919 ‎‡a identifyingsimilarcasesindocumentnetworksusingcrossreferencestructures‏ ‎‡A Identifying Similar Cases in Document Networks Using Cross-Reference Structures‏ ‎‡9 1‏
919 ‎‡a hypothyroidisminpatientswithbipolar1disordertreatedprimarilywithlithium‏ ‎‡A Hypothyroidism in patients with bipolar I disorder treated primarily with lithium.‏ ‎‡9 1‏
919 ‎‡a functionalimpairmentintheremissionphaseofbipolardisorder‏ ‎‡A Functional impairment in the remission phase of bipolar disorder‏ ‎‡9 1‏
919 ‎‡a effectsofpostchallengeadministrationofst246ondisseminationofihdjlucvacciniavirusinnormalmiceandinimmunedeficientmicereconstitutedwithtcells‏ ‎‡A Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells‏ ‎‡9 1‏
919 ‎‡a decisionsupportenvironmentformedicalproductsafetysurveillance‏ ‎‡A Decision support environment for medical product safety surveillance‏ ‎‡9 1‏
919 ‎‡a daytimesymptomsinprimaryinsomniaaprospectiveanalysisusingecologicalmomentaryassessment‏ ‎‡A Daytime symptoms in primary insomnia: a prospective analysis using ecological momentary assessment‏ ‎‡9 1‏
919 ‎‡a considerationsonendpointselectionweightingdeterminationanduncertaintyevaluationinthebenefitriskassessmentofmedicalproduct‏ ‎‡A Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product‏ ‎‡9 1‏
919 ‎‡a commentstatisticiansstayinginvolvedinbenefitriskassessment‏ ‎‡A Comment: Statisticians Staying Involved in Benefit-Risk Assessment‏ ‎‡9 1‏
919 ‎‡a commentonshiffmanandcolleaguesnicotinepatchandlozengeareeffectiveforwomen‏ ‎‡A Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women".‏ ‎‡9 1‏
919 ‎‡a cbersexperiencewithadaptivedesignclinicaltrials‏ ‎‡A CBER’s Experience With Adaptive Design Clinical Trials‏ ‎‡9 1‏
919 ‎‡a cannaturallanguageprocessingimprovetheefficiencyofvaccineadverseeventreportreview‏ ‎‡A Can Natural Language Processing Improve the Efficiency of Vaccine Adverse Event Report Review?‏ ‎‡9 1‏
919 ‎‡a bayeswebauserfriendlyplatformforexploratorybayesiananalysisofsafetysignalsfromsmallclinicaltrials‏ ‎‡A BayesWeb: a user-friendly platform for exploratory Bayesian analysis of safety signals from small clinical trials‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 J9U|987007273600505171‏
996 ‎‡2 ISNI|0000000109969086‏
996 ‎‡2 BNF|13736409‏
996 ‎‡2 LC|nr2001001966‏
996 ‎‡2 NTA|339907959‏
996 ‎‡2 ISNI|0000000025156811‏
996 ‎‡2 ISNI|000000003738669X‏
996 ‎‡2 CAOONL|ncf11322633‏
996 ‎‡2 ISNI|0000000029890976‏
996 ‎‡2 J9U|987007272502505171‏
996 ‎‡2 ISNI|0000000025322058‏
996 ‎‡2 NUKAT|n 2006077020‏
996 ‎‡2 SUDOC|274964481‏
996 ‎‡2 J9U|987007400508005171‏
996 ‎‡2 NTA|339745851‏
996 ‎‡2 BIBSYS|8003692‏
996 ‎‡2 NTA|067814441‏
996 ‎‡2 LC|no2015061168‏
996 ‎‡2 SUDOC|153437405‏
996 ‎‡2 ISNI|0000000484444310‏
996 ‎‡2 LC|n 80124114‏
996 ‎‡2 NUKAT|n 2012078809‏
996 ‎‡2 PLWABN|9810578138605606‏
996 ‎‡2 BNF|17969009‏
996 ‎‡2 DNB|13743846X‏
996 ‎‡2 BIBSYS|5094402‏
996 ‎‡2 RERO|A012333237‏
996 ‎‡2 BNCHL|10000000000000000169563‏
996 ‎‡2 B2Q|0000037858‏
996 ‎‡2 BNF|15896274‏
996 ‎‡2 LC|n 2022020840‏
996 ‎‡2 LC|nr 96007878‏
996 ‎‡2 LC|no2013034148‏
996 ‎‡2 RERO|A025740837‏
996 ‎‡2 JPG|500111795‏
996 ‎‡2 SELIBR|212874‏
996 ‎‡2 CAOONL|ncf10089841‏
996 ‎‡2 ISNI|0000000042940587‏
996 ‎‡2 LC|n 2015059978‏
996 ‎‡2 LC|no2020144088‏
996 ‎‡2 NUKAT|n 2009160387‏
996 ‎‡2 PLWABN|9814030269705606‏
996 ‎‡2 LC|no2017031825‏
996 ‎‡2 SUDOC|066997577‏
996 ‎‡2 J9U|987007365921005171‏
996 ‎‡2 ISNI|0000000135584534‏
996 ‎‡2 LC|nr 93026542‏
996 ‎‡2 NII|DA05414962‏
996 ‎‡2 J9U|987007301854305171‏
996 ‎‡2 LC|n 88664245‏
996 ‎‡2 PLWABN|9810569236105606‏
996 ‎‡2 ISNI|0000000083053095‏
996 ‎‡2 SUDOC|117772410‏
996 ‎‡2 CAOONL|ncf10199683‏
996 ‎‡2 ISNI|0000000076957205‏
996 ‎‡2 NII|DA04397507‏
996 ‎‡2 DNB|129295205‏
996 ‎‡2 LC|nr 92030570‏
996 ‎‡2 LIH|LNB:B_g_15;=BF‏
996 ‎‡2 NLA|000035766301‏
996 ‎‡2 DNB|123388902‏
996 ‎‡2 LC|no2018109981‏
996 ‎‡2 ISNI|0000000116988015‏
996 ‎‡2 RERO|A027500963‏
996 ‎‡2 LC|nr 96032959‏
996 ‎‡2 DNB|135039142‏
996 ‎‡2 LC|no2015036650‏
996 ‎‡2 ISNI|0000000033761552‏
996 ‎‡2 DNB|129729299‏
996 ‎‡2 LC|no2014123881‏
996 ‎‡2 LIH|LNB:BZ3_o_;=B_k_‏
996 ‎‡2 ISNI|0000000054647310‏
996 ‎‡2 LC|n 88222139‏
996 ‎‡2 LC|n 95057377‏
996 ‎‡2 N6I|vtls000063115‏
996 ‎‡2 DNB|172993326‏
996 ‎‡2 ISNI|0000000081284850‏
996 ‎‡2 J9U|987007281434605171‏
996 ‎‡2 DNB|1256952982‏
996 ‎‡2 NII|DA05173957‏
996 ‎‡2 RERO|A022928625‏
996 ‎‡2 NII|DA10404720‏
996 ‎‡2 DNB|1129193403‏
996 ‎‡2 ISNI|0000000019469715‏
996 ‎‡2 BNF|14450777‏
996 ‎‡2 SUDOC|117845248‏
996 ‎‡2 RERO|A018941723‏
996 ‎‡2 NII|DA11860940‏
996 ‎‡2 ICCU|LO1V047547‏
996 ‎‡2 DNB|1178446972‏
996 ‎‡2 CAOONL|ncf10142205‏
996 ‎‡2 ISNI|0000000114959480‏
996 ‎‡2 LC|nr 90005595‏
996 ‎‡2 ISNI|000000008273100X‏
996 ‎‡2 N6I|vtls002356578‏
996 ‎‡2 N6I|vtls000291219‏
996 ‎‡2 ISNI|0000000033195538‏
996 ‎‡2 ISNI|0000000397526385‏
996 ‎‡2 DNB|1067345523‏
996 ‎‡2 NLA|000036012645‏
996 ‎‡2 SUDOC|20397977X‏
996 ‎‡2 LC|no2016168368‏
996 ‎‡2 LC|n 88093561‏
996 ‎‡2 DNB|1061943984‏
996 ‎‡2 LC|no2006027832‏
996 ‎‡2 ISNI|0000000023501976‏
996 ‎‡2 NUKAT|n 99030663‏
996 ‎‡2 LC|n 85052501‏
996 ‎‡2 NTA|068769245‏
996 ‎‡2 J9U|987007330839505171‏
996 ‎‡2 LC|n 2008164458‏
996 ‎‡2 BNF|17082652‏
996 ‎‡2 NTA|292069855‏
996 ‎‡2 NSK|000045323‏
996 ‎‡2 ISNI|0000000075504095‏
996 ‎‡2 NII|DA02686412‏
996 ‎‡2 LNL|62397‏
996 ‎‡2 LC|nb2016011437‏
996 ‎‡2 LC|n 00100089‏
996 ‎‡2 ISNI|000000007902278X‏
996 ‎‡2 LC|n 2005050393‏
996 ‎‡2 DNB|1232692344‏
996 ‎‡2 CAOONL|ncf11400925‏
996 ‎‡2 J9U|987007523163005171‏
996 ‎‡2 CAOONL|ncf10107817‏
996 ‎‡2 J9U|987007460317305171‏
996 ‎‡2 LC|n 78013933‏
996 ‎‡2 ISNI|0000000497933252‏
996 ‎‡2 DNB|129816057X‏
996 ‎‡2 LNB|LNC10-000084204‏
996 ‎‡2 RERO|A012805800‏
996 ‎‡2 CAOONL|ncf11061795‏
996 ‎‡2 J9U|987007304393905171‏
996 ‎‡2 DNB|17189149X‏
996 ‎‡2 LC|n 2003100622‏
996 ‎‡2 ISNI|0000000049375728‏
996 ‎‡2 NUKAT|n 2017181131‏
996 ‎‡2 BIBSYS|4045056‏
996 ‎‡2 NTA|072289996‏
996 ‎‡2 NTA|070625964‏
996 ‎‡2 NTA|430146760‏
996 ‎‡2 RERO|A022796838‏
996 ‎‡2 LC|n 82062419‏
996 ‎‡2 LC|no2018142001‏
996 ‎‡2 ISNI|0000000109623667‏
996 ‎‡2 NLA|000035885672‏
996 ‎‡2 SUDOC|098035975‏
996 ‎‡2 LC|nb2010007431‏
996 ‎‡2 RERO|A022852865‏
996 ‎‡2 DBC|87097992095320‏
996 ‎‡2 LC|no2014007243‏
996 ‎‡2 NUKAT|n 2023150871‏
996 ‎‡2 ISNI|0000000021483639‏
996 ‎‡2 LIH|LNB:BM,F;=_y__h_‏
996 ‎‡2 LC|n 79072601‏
996 ‎‡2 DNB|1145708196‏
996 ‎‡2 J9U|987007267818405171‏
996 ‎‡2 ISNI|0000000356668459‏
996 ‎‡2 DNB|1210452723‏
996 ‎‡2 ISNI|0000000082019936‏
996 ‎‡2 NII|DA12301569‏
996 ‎‡2 BIBSYS|5000048‏
996 ‎‡2 CAOONL|ncf11490604‏
996 ‎‡2 J9U|987007449608305171‏
996 ‎‡2 N6I|vtls000293353‏
996 ‎‡2 W2Z|2131012‏
996 ‎‡2 J9U|987007332278505171‏
996 ‎‡2 J9U|987007324704805171‏
996 ‎‡2 LC|n 88032948‏
996 ‎‡2 ISNI|0000000023696208‏
996 ‎‡2 J9U|987007441663705171‏
996 ‎‡2 BIBSYS|90543666‏
996 ‎‡2 NUKAT|n 2008091660‏
996 ‎‡2 NKC|jx20061207005‏
996 ‎‡2 W2Z|1512647517600‏
996 ‎‡2 SUDOC|179479067‏
996 ‎‡2 CAOONL|ncf10179184‏
996 ‎‡2 ISNI|0000000081789883‏
996 ‎‡2 J9U|987007388772005171‏
996 ‎‡2 BNF|14424327‏
996 ‎‡2 BNF|16942022‏
996 ‎‡2 RERO|A027671845‏
996 ‎‡2 DNB|1284326985‏
996 ‎‡2 BIBSYS|90211502‏
996 ‎‡2 ISNI|0000000496886749‏
996 ‎‡2 ISNI|0000000078249536‏
996 ‎‡2 ISNI|0000000084291247‏
996 ‎‡2 LC|n 85352430‏
996 ‎‡2 NTA|15338333X‏
996 ‎‡2 SUDOC|23191203X‏
996 ‎‡2 ISNI|0000000030435874‏
996 ‎‡2 LC|n 2006057709‏
996 ‎‡2 LC|no2010208968‏
996 ‎‡2 LC|no2019098674‏
996 ‎‡2 J9U|987007427383705171‏
996 ‎‡2 N6I|vtls000020880‏
996 ‎‡2 ICCU|CFIV224346‏
996 ‎‡2 SZ|138196133‏
996 ‎‡2 LC|no 91011941‏
996 ‎‡2 CAOONL|ncf11446964‏
996 ‎‡2 NTA|109289625‏
996 ‎‡2 NUKAT|n 2005038966‏
996 ‎‡2 ISNI|0000000116807536‏
996 ‎‡2 DNB|134810619‏
996 ‎‡2 CAOONL|ncf12082398‏
996 ‎‡2 LC|nb 99088804‏
996 ‎‡2 LC|n 92035404‏
996 ‎‡2 J9U|987007307566205171‏
996 ‎‡2 ISNI|0000000084584963‏
996 ‎‡2 NII|DA00231342‏
996 ‎‡2 VLACC|000034806‏
996 ‎‡2 VLACC|000034807‏
996 ‎‡2 SELIBR|306660‏
996 ‎‡2 SELIBR|306661‏
996 ‎‡2 LC|n 2001067577‏
996 ‎‡2 ISNI|0000000108650313‏
996 ‎‡2 NUKAT|n 98012985‏
996 ‎‡2 LNB|LNC10-000044364‏
996 ‎‡2 SIMACOB|15922019‏
996 ‎‡2 NDL|00526019‏
996 ‎‡2 PLWABN|9810601587905606‏
996 ‎‡2 NUKAT|n 2010016714‏
996 ‎‡2 J9U|987007296289505171‏
996 ‎‡2 NII|DA0735557X‏
996 ‎‡2 LC|n 81027760‏
996 ‎‡2 LC|n 80127660‏
996 ‎‡2 LC|no2023004781‏
996 ‎‡2 CAOONL|ncf12093879‏
996 ‎‡2 LC|no2010000979‏
996 ‎‡2 BIBSYS|90532284‏
996 ‎‡2 LC|no2019113975‏
996 ‎‡2 BIBSYS|6089300‏
996 ‎‡2 ISNI|000000043392711X‏
996 ‎‡2 LC|n 50005949‏
996 ‎‡2 RERO|A027360902‏
996 ‎‡2 LC|n 50005948‏
996 ‎‡2 ISNI|0000000074859169‏
996 ‎‡2 N6I|vtls000033532‏
996 ‎‡2 DNB|122461383X‏
996 ‎‡2 J9U|987008209084405171‏
996 ‎‡2 RERO|A003816236‏
996 ‎‡2 LC|nr 96008432‏
996 ‎‡2 CAOONL|ncf10129181‏
996 ‎‡2 LC|nr2006015507‏
996 ‎‡2 NUKAT|n 02081885‏
996 ‎‡2 LC|nb2005010893‏
996 ‎‡2 LC|nb2015012903‏
996 ‎‡2 BIBSYS|9034407‏
996 ‎‡2 RERO|A012346110‏
996 ‎‡2 LC|n 87105232‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏